Accessibility Menu
 
Curaleaf logo

Curaleaf

(TSX) CURA

Current Price$4.44
Market Cap$3.44B
Since IPO (2018)-48%
5 Year-74%
1 Year+286%
1 Month+19%

Curaleaf Financials at a Glance

Market Cap

$3.44B

Revenue (TTM)

$1.29B

Net Income (TTM)

$114.13M

EPS (TTM)

$-0.20

P/E Ratio

-21.92

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$4.44

Volume

754,915

Open

$4.65

Previous Close

$4.44

Daily Range

$4.37 - $4.84

52-Week Range

$0.99 - $6.97

CURA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curaleaf

Industry

Pharmaceuticals

CEO

Boris Alexis Jordan

Headquarters

New York City, NY 10170, US

CURA Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

1%

Net Income Margin

-8%

Return on Equity

-12%

Return on Capital

0%

Return on Assets

-4%

Earnings Yield

-4.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.44B

Shares Outstanding

774.94M

Volume

754.91K

Avg. Volume

834.62K

Financials (TTM)

Gross Profit

$498.20M

Operating Income

$25.90M

EBITDA

$169.76M

Operating Cash Flow

$140.35M

Capital Expenditure

$64.55M

Free Cash Flow

$75.80M

Cash & ST Invst.

$101.39M

Total Debt

$1.04B

Curaleaf Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$318.92M

+2.9%

Gross Profit

$121.60M

-21.6%

Gross Margin

38.13%

N/A

Market Cap

$3.44B

N/A

Market Cap/Employee

$623.43K

N/A

Employees

5,519

N/A

Net Income

$68.66M

+212.4%

EBITDA

$33.86M

-44.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$935.81M

-29.1%

Accounts Receivable

$77.97M

+18.3%

Inventory

$0.00

-100.0%

Long Term Debt

$958.77M

+23.8%

Short Term Debt

$83.25M

+15.1%

Return on Assets

-3.65%

N/A

Return on Invested Capital

0.44%

N/A

Free Cash Flow

$3.94M

-83.4%

Operating Cash Flow

$20.64M

-48.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BHC.TOBausch Health Companies Inc.
$7.33-1.87%
CRON.TOCronos Group Inc.
$3.58-0.83%
TLRY.TOTilray Brands, Inc.
$7.18-1.37%
HLS.TOHLS Therapeutics Inc.
$4.53-1.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.93-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.37+0.02%
NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF
$5.02-0.03%

Questions About CURA

What is the current price of Curaleaf?

Curaleaf is trading at CA$4.44 per share.

What is the 52-week range for Curaleaf?

Over the past 52 weeks, Curaleaf has traded between CA$0.99 and CA$6.98.

How much debt does Curaleaf have?

As of the most recent reporting period, Curaleaf reported total debt of $1.45B.

How much cash does Curaleaf have on hand?

Curaleaf reported $148.11M in cash and cash equivalents in its most recent financial results.

What is Curaleaf’s dividend yield?

Curaleaf does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.